- MM-121 did not improve progression free survival (PFS) in patients with non-small cell lung cancer (NSCLC) -
- Company to provide pipeline review update on third quarter financial results call, November 7, 2018 -
PR Newswire
CAMBRIDGE, Mass., Oct. 19, 2018